Posted by Clinical Lab Products | Dec 13, 2010 | Cancer, Miscellaneous |
Genomic Health Inc announces the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy.
Read MorePosted by Clinical Lab Products | Dec 6, 2010 | Cancer, Miscellaneous |
This new division will create genetic diagnostic tests that determine an individual’s risk of developing a disease.
Read MorePosted by Clinical Lab Products | Nov 12, 2010 | Biochemicals & Chemical Reagents, Cancer, Prostate |
Biotechnology company MabCure Inc has generated a panel of 10 novel monoclonal antibodies against prostate cancer.
Read MorePosted by Clinical Lab Products | Oct 27, 2010 | Cancer, Miscellaneous |
Men treated for prostate cancer who were diagnosed after the start of routine screening had a significantly reduced risk of the disease spreading to other parts of the body within 10 years of treatment.
Read MorePosted by Clinical Lab Products | Oct 25, 2010 | Cancer, Miscellaneous |
GE Healthcare, a unit of General Electric Company, and Clarient Inc announced have entered into a definitive agreement for GE Healthcare to acquire Clarient.
Read More